151 related articles for article (PubMed ID: 23084899)
1. 4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.
Pechulis AD; Beck JP; Curry MA; Wolf MA; Harms AE; Xi N; Opalka C; Sweet MP; Yang Z; Vellekoop AS; Klos AM; Crocker PJ; Hassler C; Laws M; Kitchen DB; Smith MA; Olson RE; Liu S; Molino BF
Bioorg Med Chem Lett; 2012 Dec; 22(23):7219-22. PubMed ID: 23084899
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.
Park JE; Song C; Choi K; Sim T; Moon B; Roh EJ
Bioorg Med Chem Lett; 2013 Oct; 23(20):5515-8. PubMed ID: 24012181
[TBL] [Abstract][Full Text] [Related]
3. Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitor.
Shao L; Ma J; Wang F; Malcolm SC; Hewitt MC; Campbell UC; Spicer NA; Hardy LW; Schreiber R; Spear KL; Varney MA
Bioorg Med Chem Lett; 2011 Jan; 21(1):520-3. PubMed ID: 21095126
[TBL] [Abstract][Full Text] [Related]
4. 1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: further insights into a class of triple re-uptake inhibitors.
Micheli F; Cavanni P; Bettati M; Bonanomi G; Di Fabio R; Fazzolari E; Marchioro C; Roscic M; Tarsi L; Visentini F; Zonzini L; Worby A
Bioorg Med Chem; 2011 Jun; 19(11):3451-61. PubMed ID: 21550808
[TBL] [Abstract][Full Text] [Related]
5. Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.
Banister SD; Moussa IA; Beinat C; Reynolds AJ; Schiavini P; Jorgensen WT; Kassiou M
Bioorg Med Chem Lett; 2011 Jan; 21(1):38-41. PubMed ID: 21146989
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.
Gong PK; Blough BE; Brieaddy LE; Huang X; Kuhar MJ; Navarro HA; Carroll FI
J Med Chem; 2007 Jul; 50(15):3686-95. PubMed ID: 17602602
[TBL] [Abstract][Full Text] [Related]
7. 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.
Meltzer PC; Butler D; Deschamps JR; Madras BK
J Med Chem; 2006 Feb; 49(4):1420-32. PubMed ID: 16480278
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.
Paudel S; Cao Y; Guo S; An B; Kim KM; Cheon SH
Bioorg Med Chem; 2015 Oct; 23(19):6418-26. PubMed ID: 26337019
[TBL] [Abstract][Full Text] [Related]
9. The synthesis and biological evaluation of 2-(3-methyl or 3-phenylisoxazol-5-yl)-3-aryl-8-thiabicyclo[3.2.1]octanes.
Purushotham M; Sheri A; Pham-Huu DP; Madras BK; Janowsky A; Meltzer PC
Bioorg Med Chem Lett; 2011 Jan; 21(1):48-51. PubMed ID: 21146984
[TBL] [Abstract][Full Text] [Related]
10. Oxa-azaspiro derivatives: a novel class of triple re-uptake inhibitors.
Bettati M; Cavanni P; Di Fabio R; Oliosi B; Perini O; Scheid G; Tedesco G; Zonzini L; Micheli F
ChemMedChem; 2010 Mar; 5(3):361-6. PubMed ID: 20112329
[No Abstract] [Full Text] [Related]
11. Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.
Greiner E; Boos TL; Prisinzano TE; De Martino MG; Zeglis B; Dersch CM; Marcus J; Partilla JS; Rothman RB; Jacobson AE; Rice KC
J Med Chem; 2006 Mar; 49(5):1766-72. PubMed ID: 16509591
[TBL] [Abstract][Full Text] [Related]
12. Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitors.
Letavic MA; Keith JM; Jablonowski JA; Stocking EM; Gomez LA; Ly KS; Miller JM; Barbier AJ; Bonaventure P; Boggs JD; Wilson SJ; Miller KL; Lord B; McAllister HM; Tognarelli DJ; Wu J; Abad MC; Schubert C; Lovenberg TW; Carruthers NI
Bioorg Med Chem Lett; 2007 Feb; 17(4):1047-51. PubMed ID: 17127059
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological and behavioral characterization of D-473, an orally active triple reuptake inhibitor targeting dopamine, serotonin and norepinephrine transporters.
Dutta AK; Santra S; Sharma H; Voshavar C; Xu L; Mabrouk O; Antonio T; Reith ME
PLoS One; 2014; 9(11):e113420. PubMed ID: 25427177
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.
Carroll FI; Blough BE; Abraham P; Mills AC; Holleman JA; Wolckenhauer SA; Decker AM; Landavazo A; McElroy KT; Navarro HA; Gatch MB; Forster MJ
J Med Chem; 2009 Nov; 52(21):6768-81. PubMed ID: 19821577
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the understanding of the interaction of antidepressant drugs with serotonin and norepinephrine transporters.
Andersen J; Kristensen AS; Bang-Andersen B; Strømgaard K
Chem Commun (Camb); 2009 Jul; (25):3677-92. PubMed ID: 19557250
[TBL] [Abstract][Full Text] [Related]
16. The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.
Angus D; Bingham M; Buchanan D; Dunbar N; Gibson L; Goodwin R; Haunsø A; Houghton A; Huggett M; Morphy R; Napier S; Nimz O; Passmore J; Walker G
Bioorg Med Chem Lett; 2011 Jan; 21(1):271-5. PubMed ID: 21112782
[TBL] [Abstract][Full Text] [Related]
17. Further SAR studies of piperidine-based analogues of cocaine. 2. Potent dopamine and serotonin reuptake inhibitors.
Tamiz AP; Zhang J; Flippen-Anderson JL; Zhang M; Johnson KM; Deschaux O; Tella S; Kozikowski AP
J Med Chem; 2000 Mar; 43(6):1215-22. PubMed ID: 10737754
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.
Mahaney PE; Kim CY; Coghlan RD; Cohn ST; Heffernan GD; Huselton CA; Terefenko EA; Vu AT; Zhang P; Burroughs KD; Cosmi SA; Bray JA; Johnston GH; Deecher DC; Trybulski EJ
Bioorg Med Chem Lett; 2009 Oct; 19(19):5807-10. PubMed ID: 19713106
[TBL] [Abstract][Full Text] [Related]
19. Structure-Activity Relationships of Novel Thiazole-Based Modafinil Analogues Acting at Monoamine Transporters.
Kalaba P; Ilić M; Aher NY; Dragačević V; Wieder M; Zehl M; Wackerlig J; Beyl S; Sartori SB; Ebner K; Roller A; Lukic N; Beryozkina T; Gonzalez ERP; Neill P; Khan JA; Bakulev V; Leban JJ; Hering S; Pifl C; Singewald N; Lubec J; Urban E; Sitte HH; Langer T; Lubec G
J Med Chem; 2020 Jan; 63(1):391-417. PubMed ID: 31841637
[TBL] [Abstract][Full Text] [Related]
20. Further structure-activity relationship studies of piperidine-based monoamine transporter inhibitors: effects of piperidine ring stereochemistry on potency. Identification of norepinephrine transporter selective ligands and broad-spectrum transporter inhibitors.
He R; Kurome T; Giberson KM; Johnson KM; Kozikowski AP
J Med Chem; 2005 Dec; 48(25):7970-9. PubMed ID: 16335921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
